Vincenza Conteduca

Statistics

Publications

Citations

4.7K

H-Index

Active since

2008

Affiliations

Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori(Current)

Istituti di Ricovero e Cura a Carattere Scientifico

Cornell University

University of Foggia

Ospedale Santa Chiara

Vincenza Conteduca is an author at Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori specializing in medicine, oncology, and prostate cancer.

ORCID

Publications per year

2008–2024

Publications

Plasma <i>AR</i> and abiraterone-resistant prostate cancer

Alessandro Romanel, Delila Gasi Tandefelt, Vincenza Conteduca et al. · Science Translational Medicine · 2015 · 441 citations · Full text

Medicine, Oncology, Pharmacology +14

Clinical features of neuroendocrine prostate cancer

Vincenza Conteduca, Clara Oromendia, Kenneth Eng et al. · European Journal of Cancer · 2019 · 363 citations

Medicine, Oncology, Urology +14

Androgen receptor gene status in plasma DNA associates with worse outcome on enzalutamide or abiraterone for castration-resistant prostate cancer: a multi-institution correlative biomarker study

Vincenza Conteduca, Daniel Wetterskog, Mansour T. A. Sharabiani et al. · Annals of Oncology · 2017 · 269 citations · Full text

Medicine, Oncology, Pharmacology +17

Pegylated interferon-α, ribavirin, and rituximab combined therapy of hepatitis C virus–related mixed cryoglobulinemia: a long-term study

Franco Dammacco, Felicia Anna Tucci, Gianfranco Lauletta et al. · Blood · 2010 · 246 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +16

Delta-like protein 3 expression and therapeutic targeting in neuroendocrine prostate cancer

Loredana Puca, Katie Gavyert, Verena Sailer et al. · Science Translational Medicine · 2019 · 209 citations · Full text

Medicine, Oncology, Pharmacology +17

1–5 of 71